Huntington's disease and cancer: Common genetic mechanism?
The consistently decreased incidence of cancer in patients with polyglutamine (polyQ) diseases suggests that a common mechanism protects against the development of cancer. This feature could be related to the polyQ-tract expansion seen in these diseases. Further studies are warranted to investigate the underlying mechanisms linking cancer and polyQ diseases. (Free registration required.) Lancet Oncology, The (4/2012)